Breaking News

Yesterday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Recommendations
Moderna has multiple booster candidates to combat omicron, says Piper Sandler » 20:38
11/28/21
11/28
20:38
11/28/21
20:38
MRNA

Moderna

$334.00 /

+60.73 (+22.22%)

Piper Sandler analyst…

Piper Sandler analyst Edward Tenthoff reiterates an Overweight rating on Moderna with a $348 price target after the company announced plans to combat the new omicron variant. Moderna is measuring protection of a higher dose mRNA-1273 booster against omicron and is already testing two multi-valent boosters in the clinic including mRNA-1273.211 and mRNA-1273.213, Tenthoff tells investors in a research note. In addition, the company will rapidly develop an omicron-specific booster mRNA-1273.529, which could enter the clinic within 60-90 days, says the analyst. He says Moderna is in a better position to develop a novel Covid-19 vaccine and now has capacity to manufacture several hundred million vaccine doses every month. SARS-CoV-2 "is not going away and will provide years of future revenues" for Moderna, contends Tenthoff.

ShowHide Related Items >><<
MRNA Moderna
$334.00 /

+60.73 (+22.22%)

MRNA Moderna
$334.00 /

+60.73 (+22.22%)

11/26/21 Piper Sandler
Moderna has been preparing for emergence of new variants, says Piper Sandler
11/23/21 Morgan Stanley
Positive flu vaccine data can drive Moderna 10%-20% higher, says Morgan Stanley
11/19/21 Piper Sandler
Moderna can gain share from Pfizer in booster market, says Piper Sandler
11/12/21 Piper Sandler
Piper keeps $348 target on Moderna after solid tumor data
MRNA Moderna
$334.00 /

+60.73 (+22.22%)

MRNA Moderna
$334.00 /

+60.73 (+22.22%)

MRNA Moderna
$334.00 /

+60.73 (+22.22%)

MRNA Moderna
$334.00 /

+60.73 (+22.22%)

Hot Stocks
Fly Intel: Top five weekend stock stories » 20:07
11/28/21
11/28
20:07
11/28/21
20:07
MRNA

Moderna

$334.00 /

+60.73 (+22.22%)

, AMZN

Amazon.com

$3,503.50 /

-76.25 (-2.13%)

, BERY

Berry Global

$66.49 /

+1.31 (+2.01%)

, NIO

Nio

$39.88 /

-1.55 (-3.74%)

, XPEV

XPeng

$51.01 /

-3.43 (-6.30%)

, LI

Li Auto

$32.66 /

-0.005 (-0.02%)

, DIS

Disney

$147.82 /

-3.52 (-2.33%)

, IBM

IBM

$115.50 /

-1.21 (-1.04%)

, THRM

Gentherm

$83.98 /

-4.06 (-4.61%)

Catch up on the…

Catch up on the weekend's top five stories with this list compiled by The Fly: 1. Moderna (MRNA) Chief Medical Officer Paul Burton said he suspects the new omicron coronavirus variant may elude current vaccines, and if so, a reformulated shot could be available early in the new year, Bloomberg's Joe Easton reported. "We should know about the ability of the current vaccine to provide protection in the next couple of weeks," Burton said Sunday on the BBC's "Andrew Marr Show." "If we have to make a brand new vaccine, I think that's going to be early 2022 before that's really going to be available in large quantities," he said. "The remarkable thing about the mRNA vaccines, the Moderna platform, is that we can move very fast," he added. Meanwhile, a senior Amazon.com (AMZN) executive said it remains too early to predict how the Omicron coronavirus variant will impact consumer spending during the holiday season but suggested that shoppers will press ahead for now, Reuters' Mike Spector reports. Clark said he was "incredibly optimistic" about the ability of scientists and pharmaceutical companies that have developed effective vaccines to respond to the new variant while shoppers take stock of developments. 2. Activist investor Ancora Holdings is pushing Berry Global (BERY) to explore a sale, The Wall Street Journal's Cara Lombardo reported. Ancora, which owns about 1% of Berry Global, is urging it to explore strategic alternatives including a possible sale and make other changes, according to a copy of a letter the activist sent to the company's board Sunday that was viewed by The Wall Street Journal. 3. Buying growth stocks when profits are just a rumor can feel like tempting fate. But some companies reward investors' faith, Al Root wrote in this week's edition of Barron's. That looks to be the case with a trio of electric-vehicle makers, namely China's NIO (NIO), XPeng (XPEV), and Li Auto (LI), the author contended. The Chinese EV players will grow sales, on a combined basis, roughly 160% in 2021, leaving them trading at some 6.5 times next year's estimated sales, the publication added. 4. Disney's (DIS) original musical adventure "Encanto" won the Thanksgiving weekend domestic box office, with a Wednesday-Sunday opening of $40.3M. This was the best start of the pandemic era for an animated title, and that includes the $27M for the three-day weekend. Overseas, the movie earned $29.3M for a global total of $69.6M. 5. IBM (IBM) and Gentherm (THRM) saw positive mentions in this week's edition of Barron's.

ShowHide Related Items >><<
XPEV XPeng
$51.01 /

-3.43 (-6.30%)

THRM Gentherm
$83.98 /

-4.06 (-4.61%)

NIO Nio
$39.88 /

-1.55 (-3.74%)

MRNA Moderna
$334.00 /

+60.73 (+22.22%)

LI Li Auto
$32.66 /

-0.005 (-0.02%)

IBM IBM
$115.50 /

-1.21 (-1.04%)

DIS Disney
$147.82 /

-3.52 (-2.33%)

BERY Berry Global
$66.49 /

+1.31 (+2.01%)

AMZN Amazon.com
$3,503.50 /

-76.25 (-2.13%)

MRNA Moderna
$334.00 /

+60.73 (+22.22%)

11/26/21 Piper Sandler
Moderna has been preparing for emergence of new variants, says Piper Sandler
11/23/21 Morgan Stanley
Positive flu vaccine data can drive Moderna 10%-20% higher, says Morgan Stanley
11/19/21 Piper Sandler
Moderna can gain share from Pfizer in booster market, says Piper Sandler
11/12/21 Piper Sandler
Piper keeps $348 target on Moderna after solid tumor data
AMZN Amazon.com
$3,503.50 /

-76.25 (-2.13%)

11/24/21 JPMorgan
Amazon should surpass Walmart as largest retailer in 2022, says JPMorgan
11/22/21 Guggenheim
Amazon.com assumed with a Buy at Guggenheim
11/19/21 RBC Capital
Williams-Sonoma price target raised to $219 from $199 at RBC Capital
11/18/21 Bernstein
Amazon card news in the U.K. 'clearly a show of strength,' says Bernstein
BERY Berry Global
$66.49 /

+1.31 (+2.01%)

11/24/21 Raymond James
Berry Global initiated with a Market Perform at Raymond James
11/22/21 Citi
Berry Global price target raised to $89 from $84 at Citi
10/12/21 Mizuho
Berry Global initiated with a Neutral at Mizuho
10/01/21 JPMorgan
JPMorgan downgrades Silgan to sell on food can demand concerns
NIO Nio
$39.88 /

-1.55 (-3.74%)

11/23/21 Citi
Citi says Nio shares oversold after offering, keeps $87 target
11/11/21 Mizuho
Nio price target lowered to $65 from $67 at Mizuho
11/11/21 Citi
Nio price target raised to $87 from $70 at Citi
11/04/21 Deutsche Bank
Nio price target raised to $70 from $60 at Deutsche Bank
XPEV XPeng
$51.01 /

-3.43 (-6.30%)

11/24/21 BofA
XPeng price target raised to $66 from $63 at BofA
11/24/21 Citi
XPeng price target raised to $92 from $87 at Citi
11/11/21 Citi
XPeng price target raised to $87 from $53.40 at Citi
10/28/21
Fly Intel: Top five analyst initiations
LI Li Auto
$32.66 /

-0.005 (-0.02%)

11/11/21 Citi
Li Auto price target raised to $200 from $165 at Citi
10/28/21 Bernstein
Bernstein starts Li Auto at Outperform, sees EVs as 'future' of Chinese autos
10/28/21 Bernstein
Li Auto initiated with an Outperform at Bernstein
DIS Disney
$147.82 /

-3.52 (-2.33%)

11/22/21 Wells Fargo
Disney price target lowered to $196 from $203 at Wells Fargo
11/16/21 Citi
Disney price target lowered to $210 from $230 at Citi
11/15/21 Roth Capital
DraftKings price target lowered to $34 from $39 at Roth Capital
11/15/21 Deutsche Bank
Disney price target lowered to $191 from $200 at Deutsche Bank
IBM IBM
$115.50 /

-1.21 (-1.04%)

10/28/21 Credit Suisse
IBM assumed with an Outperform at Credit Suisse
10/21/21 Morgan Stanley
IBM's Q3 'a pause on the path to improving growth,' says Morgan Stanley
10/06/21 Evercore ISI
IBM removed from Tactical Outperform list at Evercore ISI
10/05/21 Credit Suisse
IBM price target raised to $176 from $167 at Credit Suisse
THRM Gentherm
$83.98 /

-4.06 (-4.61%)

10/28/21 Roth Capital
Gentherm price target lowered to $85 from $92 at Roth Capital
10/27/21
Fly Intel: Top five analyst initiations
10/27/21 Seaport Global
Gentherm initiated with a Buy at Seaport Global
09/22/21
Fly Intel: Top five analyst initiations
XPEV XPeng
$51.01 /

-3.43 (-6.30%)

THRM Gentherm
$83.98 /

-4.06 (-4.61%)

NIO Nio
$39.88 /

-1.55 (-3.74%)

MRNA Moderna
$334.00 /

+60.73 (+22.22%)

LI Li Auto
$32.66 /

-0.005 (-0.02%)

IBM IBM
$115.50 /

-1.21 (-1.04%)

DIS Disney
$147.82 /

-3.52 (-2.33%)

BERY Berry Global
$66.49 /

+1.31 (+2.01%)

AMZN Amazon.com
$3,503.50 /

-76.25 (-2.13%)

  • 13
    Aug
  • 14
    Dec
  • 09
    Dec
  • 04
    Dec
XPEV XPeng
$51.01 /

-3.43 (-6.30%)

THRM Gentherm
$83.98 /

-4.06 (-4.61%)

NIO Nio
$39.88 /

-1.55 (-3.74%)

MRNA Moderna
$334.00 /

+60.73 (+22.22%)

IBM IBM
$115.50 /

-1.21 (-1.04%)

DIS Disney
$147.82 /

-3.52 (-2.33%)

BERY Berry Global
$66.49 /

+1.31 (+2.01%)

AMZN Amazon.com
$3,503.50 /

-76.25 (-2.13%)

XPEV XPeng
$51.01 /

-3.43 (-6.30%)

NIO Nio
$39.88 /

-1.55 (-3.74%)

MRNA Moderna
$334.00 /

+60.73 (+22.22%)

LI Li Auto
$32.66 /

-0.005 (-0.02%)

IBM IBM
$115.50 /

-1.21 (-1.04%)

DIS Disney
$147.82 /

-3.52 (-2.33%)

BERY Berry Global
$66.49 /

+1.31 (+2.01%)

AMZN Amazon.com
$3,503.50 /

-76.25 (-2.13%)

XPEV XPeng
$51.01 /

-3.43 (-6.30%)

NIO Nio
$39.88 /

-1.55 (-3.74%)

MRNA Moderna
$334.00 /

+60.73 (+22.22%)

LI Li Auto
$32.66 /

-0.005 (-0.02%)

IBM IBM
$115.50 /

-1.21 (-1.04%)

DIS Disney
$147.82 /

-3.52 (-2.33%)

AMZN Amazon.com
$3,503.50 /

-76.25 (-2.13%)

Periodicals
European telecoms want U.S. tech giants to help fund network costs, Reuters says » 18:15
11/28/21
11/28
18:15
11/28/21
18:15
DTEGY

Deutsche Telekom

$18.37 /

-0.654 (-3.44%)

, VOD

Vodafone

$14.93 /

-0.4 (-2.61%)

, NFLX

Netflix

$661.12 /

+3.12 (+0.47%)

, GOOGL

Alphabet Class A

$2,842.01 /

-78.89 (-2.70%)

, GOOG

Alphabet

$2,854.20 /

-80.05 (-2.73%)

, FB

Facebook; also tag MVRS

$333.39 /

-7.78 (-2.28%)

, MVRS

Meta

/

+

U.S. tech giants should…

U.S. tech giants should bear some of the costs of developing Europe's telecoms networks because they use them so heavily, chief executives of Deutsche Telekom (DTEGY), Vodafone (VOD) and 11 other major European telecoms companies said on Monday, Reuters' Foo Yun Chee reports. The call by the CEOs comes as the telecoms industry faces massive investments for 5G, fiber and cable networks to cope with data and cloud services provided by Netflix (NFLX) and Google's (GOOGL) YouTube and Facebook (FB), the author notes. Reference Link

ShowHide Related Items >><<
VOD Vodafone
$14.93 /

-0.4 (-2.61%)

NFLX Netflix
$661.12 /

+3.12 (+0.47%)

GOOGL Alphabet Class A
$2,842.01 /

-78.89 (-2.70%)

GOOG Alphabet
$2,854.20 /

-80.05 (-2.73%)

FB Facebook; also tag MVRS
$333.39 /

-7.78 (-2.28%)

DTEGY Deutsche Telekom
$18.37 /

-0.654 (-3.44%)

DTEGY Deutsche Telekom
$18.37 /

-0.654 (-3.44%)

11/15/21 UBS
Deutsche Telekom price target raised to EUR 24.50 from EUR 24.20 at UBS
10/18/21 Deutsche Bank
Deutsche Telekom named short-term investment idea at Deutsche Bank
10/14/21 JPMorgan
Deutsche Telekom price target lowered to EUR 28 from EUR 29 at JPMorgan
09/10/21 UBS
Deutsche Telekom price target raised to EUR 24.20 from EUR 24 at UBS
VOD Vodafone
$14.93 /

-0.4 (-2.61%)

11/18/21 UBS
Vodafone price target raised to 188 GBp from 187 GBp at UBS
10/28/21 JPMorgan
Vodafone price target lowered to 160 GBp from 165 GBp at JPMorgan
10/18/21 Deutsche Bank
Vodafone named short-term investment idea at Deutsche Bank
09/07/21 Bernstein
Vodafone initiated with an Outperform at Bernstein
NFLX Netflix
$661.12 /

+3.12 (+0.47%)

11/22/21 Wells Fargo
Disney price target lowered to $196 from $203 at Wells Fargo
11/17/21 Goldman Sachs
Amazon named top Americas Internet pick for 2022 at Goldman Sachs
11/15/21 KeyBanc
Netflix price target raised to $725 from $690 at KeyBanc
11/15/21 JPMorgan
Netflix entering 'strongest content quarter ever,' says JPMorgan
GOOGL Alphabet Class A
$2,842.01 /

-78.89 (-2.70%)

11/02/21 Morgan Stanley
Alphabet price target raised to $3,200 from $3,000 at Morgan Stanley
10/27/21 BMO Capital
Alphabet target raised to $3,200 from $3,000 at BMO Capital
10/27/21 Wedbush
Alphabet Class A price target raised to $3,530 from $3,424 at Wedbush
GOOG Alphabet
$2,854.20 /

-80.05 (-2.73%)

10/27/21 Jefferies
Alphabet price target raised to $3,500 from $3,325 at Jefferies
FB Facebook; also tag MVRS
$333.39 /

-7.78 (-2.28%)

11/19/21 JMP Securities
DoubleVerify may see $200M opportunity from Facebook news, says JMP Securities
11/09/21 Morgan Stanley
Twitter price target lowered to $62 from $68 at Morgan Stanley
11/09/21 Susquehanna
AMD price target raised to $175 from $145 at Susquehanna
MVRS Meta
/

+

11/08/21 Stifel
AMD-Meta partnership shows secular growth thesis 'gaining momentum,' says Stifel
10/28/21 Piper Sandler
Facebook name change a 'big, bold and risky bet,' says Piper Sandler
NFLX Netflix
$661.12 /

+3.12 (+0.47%)

GOOGL Alphabet Class A
$2,842.01 /

-78.89 (-2.70%)

FB Facebook; also tag MVRS
$333.39 /

-7.78 (-2.28%)

VOD Vodafone
$14.93 /

-0.4 (-2.61%)

NFLX Netflix
$661.12 /

+3.12 (+0.47%)

MVRS Meta
/

+

GOOGL Alphabet Class A
$2,842.01 /

-78.89 (-2.70%)

FB Facebook; also tag MVRS
$333.39 /

-7.78 (-2.28%)

DTEGY Deutsche Telekom
$18.37 /

-0.654 (-3.44%)

VOD Vodafone
$14.93 /

-0.4 (-2.61%)

NFLX Netflix
$661.12 /

+3.12 (+0.47%)

GOOGL Alphabet Class A
$2,842.01 /

-78.89 (-2.70%)

FB Facebook; also tag MVRS
$333.39 /

-7.78 (-2.28%)

DTEGY Deutsche Telekom
$18.37 /

-0.654 (-3.44%)

VOD Vodafone
$14.93 /

-0.4 (-2.61%)

NFLX Netflix
$661.12 /

+3.12 (+0.47%)

GOOGL Alphabet Class A
$2,842.01 /

-78.89 (-2.70%)

FB Facebook; also tag MVRS
$333.39 /

-7.78 (-2.28%)

VOD Vodafone
$14.93 /

-0.4 (-2.61%)

Periodicals
Tesla to start production in Germany in December, Bloomberg reports » 15:32
11/28/21
11/28
15:32
11/28/21
15:32
TSLA

Tesla

$1,081.00 /

-35 (-3.14%)

Tesla will launch its…

Tesla will launch its overdue German production operations in December, estimating as many as 30,000 vehicles will be manufactured there in the first half of 2022, Bloomberg's Karin Matussek reports, citing Automobilwoche. Production was to have begun in July but was delayed because the company hadn't received environmental clearance. Local regulators are expected to grant the necessary permits within days, the magazine said. Reference Link

ShowHide Related Items >><<
TSLA Tesla
$1,081.00 /

-35 (-3.14%)

TSLA Tesla
$1,081.00 /

-35 (-3.14%)

11/24/21 Morgan Stanley
Morgan Stanley stays Underweight Ford, admits to being wrong after near-double
11/19/21 Morgan Stanley
Apple Car would be 'ultimate EV bear case,' says Morgan Stanley
11/19/21 Wedbush
Tesla price target raised to $1,400 from $1,100 at Wedbush
11/17/21 Exane BNP Paribas
Exane BNP Paribas boosts Tesla target to $780, keeps Underpeform rating
TSLA Tesla
$1,081.00 /

-35 (-3.14%)

TSLA Tesla
$1,081.00 /

-35 (-3.14%)

TSLA Tesla
$1,081.00 /

-35 (-3.14%)

TSLA Tesla
$1,081.00 /

-35 (-3.14%)

Periodicals
Moderna new vaccine for Omicron may be ready in early 2022, Bloomberg reports » 15:23
11/28/21
11/28
15:23
11/28/21
15:23
MRNA

Moderna

$334.00 /

+60.73 (+22.22%)

Moderna Chief Medical…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MRNA Moderna
$334.00 /

+60.73 (+22.22%)

MRNA Moderna
$334.00 /

+60.73 (+22.22%)

11/26/21 Piper Sandler
Moderna has been preparing for emergence of new variants, says Piper Sandler
11/23/21 Morgan Stanley
Positive flu vaccine data can drive Moderna 10%-20% higher, says Morgan Stanley
11/19/21 Piper Sandler
Moderna can gain share from Pfizer in booster market, says Piper Sandler
11/12/21 Piper Sandler
Piper keeps $348 target on Moderna after solid tumor data
MRNA Moderna
$334.00 /

+60.73 (+22.22%)

MRNA Moderna
$334.00 /

+60.73 (+22.22%)

MRNA Moderna
$334.00 /

+60.73 (+22.22%)

MRNA Moderna
$334.00 /

+60.73 (+22.22%)

Friday
Hot Stocks
Moderna testing existing and new variant-specific vaccine candidates for Omicron » 15:37
11/26/21
11/26
15:37
11/26/21
15:37
MRNA

Moderna

$331.10 /

+57.83 (+21.16%)

Moderna announced updates…

Moderna announced updates to its strategy to address SARS-CoV-2 variants of concern, given the emergence of the B.1.1.529, or "Omicron," variant. "The recently described Omicron variant includes mutations seen in the Delta variant that are believed to increase transmissibility and mutations seen in the Beta and Delta variants that are believed to promote immune escape. The combination of mutations represents a significant potential risk to accelerate the waning of natural and vaccine-induced immunity. A booster dose of an authorized vaccine represents the only currently available strategy for boosting waning immunity. The Moderna COVID-19 vaccine - mRNA-1273 - is authorized as a booster for many populations at the 50 microgram dose level. The Company is working rapidly to test the ability of the current vaccine dose to neutralize the Omicron variant and data is expected in the coming weeks. Since early 2021, Moderna has advanced a comprehensive strategy to anticipate new variants of concern. This strategy includes three levels of response should the currently authorized 50 microgram booster dose of mRNA-1273 prove insufficient to boost waning immunity against the Omicron variant," the company stated. Moderna said it has already tested a higher dose booster of mRNA-1273, 100 microgram, in healthy adults. Moderna has completed dosing of 306 participants in a safety and immunogenicity study of this high dose booster. The 100 microgram dose of mRNA-1273 has also recently been studied by the National Institutes of Health in the U.S. and has generally resulted in the highest neutralizing titers against prior SARS-CoV-2 strains. Moderna is working to rapidly test sera from its high dose booster recipients in neutralizing assays to determine if the 100 microgram dose provides superior neutralizing protection against Omicron. Second, Moderna is already studying two multi-valent booster candidates in the clinic that were designed to anticipate mutations such as those that have emerged in the Omicron variant. The first candidate, mRNA-1273.211, includes several mutations present in the Omicron variant that were also present in the Beta variant of concern. The company has completed dosing in a potentially pivotal safety and immunogenicity study of mRNA-1273.211 at the 50 microgram and 100 microgram dose levels. A second multi-valent candidate, mRNA-1273.213, includes many of the mutations present in the Omicron variant that were also present in the Beta and Delta variants. The company has completed dosing at the 100 microgram dose level and also plans to explore the 50 microgram dose level in approximately 584 participants. Moderna will rapidly expand testing of sera from completed and ongoing multi-valent booster studies to determine if these multi-valent candidates are able to provide superior neutralizing protection against Omicron. Third, Moderna will rapidly advance an Omicron-specific booster candidate, mRNA-1273.529. This candidate is part of the company's strategy to advance variant-specific candidates for a subset of variants of significant concern. During 2021 this has already included Beta- and Delta-specific boosters. The company has repeatedly demonstrated the ability to advance new candidates to clinical testing in 60-90 days. "From the beginning, we have said that as we seek to defeat the pandemic, it is imperative that we are proactive as the virus evolves. The mutations in the Omicron variant are concerning and for several days, we have been moving as fast as possible to execute our strategy to address this variant. We have three lines of defense that we are advancing in parallel: we have already evaluated a higher dose booster of mRNA-1273, second, we are already studying two multi-valent booster candidates in the clinic that were designed to anticipate mutations such as those that have emerged in the Omicron variant and data is expected in the coming weeks, and third, we are rapidly advancing a Omicron-specific booster candidate," said Stephane Bancel, CEO of Moderna.

ShowHide Related Items >><<
MRNA Moderna
$331.10 /

+57.83 (+21.16%)

MRNA Moderna
$331.10 /

+57.83 (+21.16%)

11/26/21 Piper Sandler
Moderna has been preparing for emergence of new variants, says Piper Sandler
11/23/21 Morgan Stanley
Positive flu vaccine data can drive Moderna 10%-20% higher, says Morgan Stanley
11/19/21 Piper Sandler
Moderna can gain share from Pfizer in booster market, says Piper Sandler
11/12/21 Piper Sandler
Piper keeps $348 target on Moderna after solid tumor data
MRNA Moderna
$331.10 /

+57.83 (+21.16%)

MRNA Moderna
$331.10 /

+57.83 (+21.16%)

MRNA Moderna
$331.10 /

+57.83 (+21.16%)

MRNA Moderna
$331.10 /

+57.83 (+21.16%)

On The Fly
Wall Street in Fives - Must Read Lists for Friday » 13:21
11/26/21
11/26
13:21
11/26/21
13:21
MRNA

Moderna

$332.27 /

+59 (+21.59%)

, PFE

Pfizer

$54.12 /

+3.22 (+6.33%)

, MRK

Merck

$78.24 /

-4.06 (-4.93%)

, BNTX

BioNTech

$353.00 /

+47.71 (+15.63%)

, OCGN

Ocugen

$6.47 /

-0.62 (-8.74%)

, AAPL

Apple

$157.52 /

-4.47 (-2.76%)

, ZM

Zoom Video

$220.65 /

+12.41 (+5.96%)

, PTON

Peloton

$46.33 /

+2.44 (+5.56%)

, AAL

American Airlines

$17.49 /

-1.97 (-10.12%)

, UAL

United Airlines

$42.44 /

-4.29 (-9.18%)

, DAL

Delta Air Lines

$36.20 /

-3.48 (-8.77%)

, CCL

Carnival

$17.98 /

-2.175 (-10.79%)

, NCLH

Norwegian Cruise Line

$20.22 /

-2.4 (-10.61%)

, RCL

Royal Caribbean

$68.14 /

-10.21 (-13.03%)

, PDD

Pinduoduo

$68.52 /

-12.85 (-15.79%)

, DIDI

Didi

$7.87 /

-0.24 (-2.96%)

, QSR

Restaurant Brands

$57.95 /

-0.815 (-1.39%)

, AMZN

Amazon.com

$3,509.00 /

-70.75 (-1.98%)

, HUBS

HubSpot

$806.16 /

+3.9899 (+0.50%)

, TSLA

Tesla

$1,082.15 /

-33.85 (-3.03%)

, BABA

Alibaba

$133.30 /

-3.32 (-2.43%)

, QGEN

Qiagen

$56.42 /

+1.81 (+3.31%)

, LIAN

LianBio

$16.06 /

+0.49 (+3.15%)

, NVO

Novo Nordisk

$108.19 /

-0.775 (-0.71%)

, CANF

Can-Fite BioPharma

$1.23 /

+0.05 (+4.24%)

, UK

Ucommune International

/

+

, MLCO

Melco Resorts & Entertainment

$10.39 /

-1.225 (-10.55%)

, SCHYY

Sands China

$26.54 /

+0.84 (+3.27%)

, SJMHY

SJM Holdings

$3.09 /

+ (+0.00%)

, WYNMF

Wynn Macau

/

+

, GXYEF

Galaxy Entertainment

$6.14 /

+ (+0.00%)

, MDEVF

Melco International

$1.40 /

+ (+0.00%)

, MCHVF

MGM China

/

+

, MSC

Studio City

$6.66 /

-0.57 (-7.88%)

, PBR

Petrobras

$10.48 /

+ (+0.00%)

, BP

BP

$25.83 /

-1.82 (-6.58%)

, CVX

Chevron

$114.26 /

-2.94 (-2.51%)

, COP

ConocoPhillips

$71.45 /

-3.39 (-4.53%)

, XOM

Exxon Mobil

$61.17 /

-2.3 (-3.62%)

, RDS.A

Royal Dutch Shell

$42.06 /

-2.16 (-4.88%)

, TOT

TotalEnergies

/

+

Get caught up quickly on…

ShowHide Related Items >><<
ZM Zoom Video
$220.65 /

+12.41 (+5.96%)

XOM Exxon Mobil
$61.17 /

-2.3 (-3.62%)

UK Ucommune International
/

+

UAL United Airlines
$42.44 /

-4.29 (-9.18%)

TSLA Tesla
$1,082.15 /

-33.85 (-3.03%)

TOT TotalEnergies
/

+

RDS.A Royal Dutch Shell
$42.06 /

-2.16 (-4.88%)

RCL Royal Caribbean
$68.14 /

-10.21 (-13.03%)

QSR Restaurant Brands
$57.95 /

-0.815 (-1.39%)

QGEN Qiagen
$56.42 /

+1.81 (+3.31%)

PTON Peloton
$46.33 /

+2.44 (+5.56%)

PFE Pfizer
$54.12 /

+3.22 (+6.33%)

PDD Pinduoduo
$68.52 /

-12.85 (-15.79%)

PBR Petrobras
$10.48 /

+ (+0.00%)

OCGN Ocugen
$6.47 /

-0.62 (-8.74%)

NVO Novo Nordisk
$108.19 /

-0.775 (-0.71%)

NCLH Norwegian Cruise Line
$20.22 /

-2.4 (-10.61%)

MSC Studio City
$6.66 /

-0.57 (-7.88%)

MRNA Moderna
$332.27 /

+59 (+21.59%)

MRK Merck
$78.24 /

-4.06 (-4.93%)

MLCO Melco Resorts & Entertainment
$10.39 /

-1.225 (-10.55%)

HUBS HubSpot
$806.16 /

+3.9899 (+0.50%)

DIDI Didi
$7.87 /

-0.24 (-2.96%)

DAL Delta Air Lines
$36.20 /

-3.48 (-8.77%)

CVX Chevron
$114.26 /

-2.94 (-2.51%)

COP ConocoPhillips
$71.45 /

-3.39 (-4.53%)

CCL Carnival
$17.98 /

-2.175 (-10.79%)

CANF Can-Fite BioPharma
$1.23 /

+0.05 (+4.24%)

BP BP
$25.83 /

-1.82 (-6.58%)

BNTX BioNTech
$353.00 /

+47.71 (+15.63%)

BABA Alibaba
$133.30 /

-3.32 (-2.43%)

AMZN Amazon.com
$3,509.00 /

-70.75 (-1.98%)

AAPL Apple
$157.52 /

-4.47 (-2.76%)

AAL American Airlines
$17.49 /

-1.97 (-10.12%)

MRNA Moderna
$332.27 /

+59 (+21.59%)

11/26/21 Piper Sandler
Moderna has been preparing for emergence of new variants, says Piper Sandler
11/23/21 Morgan Stanley
Positive flu vaccine data can drive Moderna 10%-20% higher, says Morgan Stanley
11/19/21 Piper Sandler
Moderna can gain share from Pfizer in booster market, says Piper Sandler
11/12/21 Piper Sandler
Piper keeps $348 target on Moderna after solid tumor data
PFE Pfizer
$54.12 /

+3.22 (+6.33%)

11/26/21 Citi
Pfizer can deliver novel vaccine within 100 days of sequencing, says Citi
11/26/21 Mizuho
Pfizer data on vupanorsen is mixed, says Mizuho
11/24/21 Truist
Pfizer price target raised to $58 from $43 at Truist
11/24/21 Oppenheimer
Enanta price target raised to $73 from $55 at Oppenheimer
MRK Merck
$78.24 /

-4.06 (-4.93%)

11/24/21 Truist
Merck price target raised to $95 from $92 at Truist
11/18/21 BMO Capital
Merck initiated with a Market Perform at BMO Capital
11/18/21 Stifel
Insmed fits similar 'profile' to Dicerna in terms of value, says Stifel
11/05/21 Cowen
Pfizer 'looks to have edge' in COVID oral antivirals, says Cowen
BNTX BioNTech
$353.00 /

+47.71 (+15.63%)

11/10/21
Fly Intel: Top five analyst upgrades
11/10/21 H.C. Wainwright
H.C. Wainwright upgrades BioNTech to Buy ahead of likely booster approval
11/10/21 H.C. Wainwright
BioNTech upgraded to Buy from Neutral at H.C. Wainwright
10/22/21
Fly Intel: Top five analyst initiations
OCGN Ocugen
$6.47 /

-0.62 (-8.74%)

07/26/21 Noble Capital
Ocugen initiated with an Outperform at Noble Capital
07/06/21 Roth Capital
Covaxin data continue to meet FDA efficacy threshold, says Roth Capital
06/11/21
Fly Intel: Top five analyst downgrades
06/11/21 H.C. Wainwright
Ocugen price target lowered to $10 from $12 at H.C. Wainwright
AAPL Apple
$157.52 /

-4.47 (-2.76%)

11/26/21 Wedbush
Wedbush sees Apple on pace to sell over 10M iPhones over Black Friday weekend
11/26/21
Apple to launch AR headset in 2022, TFI Asset's Kuo predicts
11/24/21 UBS
Apple demand remains strong, supply constraints improving, says UBS
11/23/21 Wells Fargo
China October mobile phone data positive for Apple, says Wells Fargo
ZM Zoom Video
$220.65 /

+12.41 (+5.96%)

11/23/21
Fly Intel: Top five analyst downgrades
11/23/21 BofA
Zoom Video downgraded to Neutral from Buy at BofA
11/23/21 Wells Fargo
Zoom Video price target lowered to $245 from $275 at Wells Fargo
11/23/21 Evercore ISI
Zoom Video price target lowered to $235 from $255 at Evercore ISI
PTON Peloton
$46.33 /

+2.44 (+5.56%)

11/16/21 Baird
Baird adds Peloton as 'Fresh Pick,' says capital raise removes overhang
11/16/21 BMO Capital
Peloton 'backpedaling again' with $1B offering, says BMO Capital
11/11/21 RBC Capital
Affirm price target raised to $175 from $130 at RBC Capital
11/09/21 JMP Securities
Peloton should be bought on weakness, says JMP Securities
AAL American Airlines
$17.49 /

-1.97 (-10.12%)

10/06/21
Fly Intel: Top five analyst downgrades
10/06/21 Goldman Sachs
American Airlines downgraded to Sell from Neutral at Goldman Sachs
08/11/21 Redburn
American Airlines initiated with a Buy at Redburn
07/27/21
Fly Intel: Top five analyst upgrades
UAL United Airlines
$42.44 /

-4.29 (-9.18%)

10/21/21 Cowen
United Airlines price target raised to $78 from $72 at Cowen
08/11/21 Redburn
United Airlines initiated with a Sell at Redburn
07/22/21 MKM Partners
United Airlines price target lowered to $61 from $65 at MKM Partners
07/22/21 Susquehanna
United Airlines price target lowered to $51 from $56 at Susquehanna
DAL Delta Air Lines
$36.20 /

-3.48 (-8.77%)

11/19/21 Wolfe Research
Delta Air Lines upgraded to Outperform from Peer Perform at Wolfe Research
10/29/21 BTIG
Call with Sharecare customers raises BTIG conviction in long-term outlook
10/14/21 Cowen
Delta Air Lines price target raised to $54 from $53 at Cowen
10/14/21 Morgan Stanley
Delta Air Lines price target lowered to $62 from $67 at Morgan Stanley
CCL Carnival
$17.98 /

-2.175 (-10.79%)

10/25/21
Fly Intel: Top five analyst downgrades
10/25/21 Citi
Citi downgrades Carnival to Neutral, sees more upside in Norwegian
10/25/21 Citi
Carnival downgraded to Neutral from Buy at Citi
10/21/21
Fly Intel: Top five analyst upgrades
NCLH Norwegian Cruise Line
$20.22 /

-2.4 (-10.61%)

11/16/21 Stifel
Norwegian Cruise Line weakness a buying opportunity, says Stifel
11/11/21 Berenberg
Norwegian Cruise Line price target raised to $27 from $25 at Berenberg
11/05/21 Deutsche Bank
Norwegian Cruise Line price target raised to $28 from $26 at Deutsche Bank
11/04/21 Wedbush
Norwegian Cruise Line price target raised to $35 from $30 at Wedbush
RCL Royal Caribbean
$68.14 /

-10.21 (-13.03%)

11/01/21 Deutsche Bank
Royal Caribbean price target lowered to $81 from $83 at Deutsche Bank
09/24/21 Stifel
Royal Caribbean price target raised to $111 from $95 at Stifel
09/22/21 Truist
Royal Caribbean price target raised to $80 from $72 at Truist
08/23/21 William Blair
Royal Caribbean estimates lowered on marketing ramp-up at William Blair
PDD Pinduoduo
$68.52 /

-12.85 (-15.79%)

11/02/21 Barclays
Pinduoduo initiated with Equal Weight, $103 target at Barclays
11/02/21 Barclays
Pinduoduo initiated with an Equal Weight at Barclays
08/25/21 BofA
Pinduoduo price target raised to $148 from $143 at BofA
08/25/21 Benchmark
Pinduoduo price target lowered to $156 from $176 at Benchmark
DIDI Didi
$7.87 /

-0.24 (-2.96%)

07/28/21 Alliance Global Partners
Alliance Global Partners bullish on Aurora Mobile despite regulatory changes
07/28/21 Alliance Global Partners
iClick Interactive price target lowered to $15 from $21 at Alliance Global
07/26/21 Atlantic Equities
Atlantic Equities downgrades DiDi to Neutral amid active investigations
07/26/21 Atlantic Equities
DiDi downgraded to Neutral from Overweight at Atlantic Equities
QSR Restaurant Brands
$57.95 /

-0.815 (-1.39%)

11/11/21
Fly Intel: Top five analyst downgrades
11/11/21 KeyBanc
Restaurant Brands downgraded to Sector Weight from Overweight at KeyBanc
10/27/21
Fly Intel: Top five analyst downgrades
10/27/21 Argus
Restaurant Brands downgraded to Hold at Argus on cost pressure, labor shortage
AMZN Amazon.com
$3,509.00 /

-70.75 (-1.98%)

11/24/21 JPMorgan
Amazon should surpass Walmart as largest retailer in 2022, says JPMorgan
11/22/21 Guggenheim
Amazon.com assumed with a Buy at Guggenheim
11/19/21 RBC Capital
Williams-Sonoma price target raised to $219 from $199 at RBC Capital
11/18/21 Bernstein
Amazon card news in the U.K. 'clearly a show of strength,' says Bernstein
HUBS HubSpot
$806.16 /

+3.9899 (+0.50%)

11/19/21 Argus
HubSpot price target raised to $970 from $930 at Argus
11/04/21 Canaccord
HubSpot price target raised to $845 from $830 at Canaccord
11/04/21 Raymond James
HubSpot price target raised to $900 from $800 at Raymond James
11/04/21 Wells Fargo
HubSpot price target raised to $860 from $835 at Wells Fargo
TSLA Tesla
$1,082.15 /

-33.85 (-3.03%)

11/24/21 Morgan Stanley
Morgan Stanley stays Underweight Ford, admits to being wrong after near-double
11/19/21 Morgan Stanley
Apple Car would be 'ultimate EV bear case,' says Morgan Stanley
11/19/21 Wedbush
Tesla price target raised to $1,400 from $1,100 at Wedbush
11/17/21 Exane BNP Paribas
Exane BNP Paribas boosts Tesla target to $780, keeps Underpeform rating
BABA Alibaba
$133.30 /

-3.32 (-2.43%)

11/24/21
Fly Intel: Top five analyst downgrades
11/24/21 Argus
Alibaba downgraded to Hold from Buy at Argus
11/23/21 Needham
Alibaba price target lowered to $230 from $330 at Needham
11/19/21 Benchmark
Alibaba price target lowered to $245 from $270 at Benchmark
QGEN Qiagen
$56.42 /

+1.81 (+3.31%)

10/14/21 Cowen
Qiagen coverage transferred at Cowen
10/14/21 Redburn
Qiagen initiated with a Buy at Redburn
07/14/21 Citi
Qiagen price target lowered to $58 from $65 at Citi
07/14/21 Kepler Cheuvreux
Qiagen downgraded to Hold from Buy at Kepler Cheuvreux
LIAN LianBio
$16.06 /

+0.49 (+3.15%)

11/26/21 BofA
LianBio initiated with a Buy at BofA
11/26/21 Goldman Sachs
LianBio initiated with a Neutral at Goldman Sachs
11/26/21 Jefferies
LianBio initiated with a Buy at Jefferies
11/24/21 Raymond James
LianBio initiated with an Outperform at Raymond James
NVO Novo Nordisk
$108.19 /

-0.775 (-0.71%)

11/19/21 RBC Capital
Dicerna downgraded to Sector Perform from Outperform at RBC Capital
11/11/21 UBS
Novo Nordisk price target raised to DKK 725 from DKK 630 at UBS
11/05/21 Deutsche Bank
Novo Nordisk price target raised to DKK 775 from DKK 735 at Deutsche Bank
CANF Can-Fite BioPharma
$1.23 /

+0.05 (+4.24%)

06/15/21 Alliance Global Partners
Can-Fite BioPharma initiated with a Buy at Alliance Global Partners
UK Ucommune International
/

+

MLCO Melco Resorts & Entertainment
$10.39 /

-1.225 (-10.55%)

11/26/21 Credit Suisse
Credit Suisse upgrades Macau stocks with 'light at the end of the tunnel'
11/24/21 Credit Suisse
Melco Resorts upgraded to Outperform from Underperform at Credit Suisse
09/28/21 Citi
Melco Resorts price target lowered to $14.50 from $24.50 at Citi
09/24/21 Credit Suisse
As Macau locks down, Credit Suisse warns of downside risk to 2022 GGR estimates
SCHYY Sands China
$26.54 /

+0.84 (+3.27%)

11/24/21 Credit Suisse
Sands China upgraded to Outperform from Neutral at Credit Suisse
11/19/21 JPMorgan
Sands China upgraded to Neutral from Underweight at JPMorgan
09/15/21 JPMorgan
Sands China downgraded to Underweight from Overweight at JPMorgan
SJMHY SJM Holdings
$3.09 /

+ (+0.00%)

11/24/21 Credit Suisse
SJM Holdings upgraded to Outperform from Neutral at Credit Suisse
09/15/21 JPMorgan
SJM Holdings downgraded to Neutral from Overweight at JPMorgan
02/08/21 JPMorgan
SJM Holdings upgraded to Overweight from Neutral at JPMorgan
WYNMF Wynn Macau
/

+

11/24/21 Credit Suisse
Wynn Macau upgraded to Outperform from Underperform at Credit Suisse
11/19/21 JPMorgan
Wynn Macau upgraded to Neutral from Underweight at JPMorgan
09/15/21 JPMorgan
Wynn Macau downgraded to Underweight from Overweight at JPMorgan
GXYEF Galaxy Entertainment
$6.14 /

+ (+0.00%)

11/24/21 Credit Suisse
Galaxy Entertainment upgraded to Outperform from Neutral at Credit Suisse
11/19/21 JPMorgan
Galaxy Entertainment upgraded to Overweight from Neutral at JPMorgan
09/15/21 JPMorgan
Galaxy Entertainment downgraded to Neutral from Overweight at JPMorgan
MDEVF Melco International
$1.40 /

+ (+0.00%)

11/24/21 Credit Suisse
Melco International upgraded to Outperform from Underperform at Credit Suisse
11/19/21 JPMorgan
Melco International upgraded to Neutral from Underweight at JPMorgan
09/15/21 JPMorgan
Melco International downgraded to Underweight from Overweight at JPMorgan
MCHVF MGM China
/

+

11/24/21 Credit Suisse
MGM China upgraded to Outperform from Underperform at Credit Suisse
09/15/21 JPMorgan
MGM China downgraded to Neutral from Overweight at JPMorgan
09/13/21 Bernstein
MGM China upgraded to Outperform from Market Perform at Bernstein
MSC Studio City
$6.66 /

-0.57 (-7.88%)

11/24/21 Credit Suisse
Studio City upgraded to Neutral from Underperform at Credit Suisse
PBR Petrobras
$10.48 /

+ (+0.00%)

11/26/21 Morgan Stanley
Morgan Stanley trims Petrobras target to $13.30 after business plan presented
11/16/21 HSBC
Petrobras upgraded to Buy from Hold at HSBC
10/14/21 HSBC
Petrobras downgraded to Hold from Buy at HSBC
10/11/21 Citi
Petrobras transferred with Buy rating at Citi
BP BP
$25.83 /

-1.82 (-6.58%)

11/09/21 Morgan Stanley
BP price target raised to 401 GBp from 388 GBp at Morgan Stanley
10/25/21 TD Securities
BP initiated with a Hold at TD Securities
10/15/21 Berenberg
BP upgraded to Buy from Hold at Berenberg
10/12/21 Morgan Stanley
BP price target raised to 388 GBp from 342 GBp at Morgan Stanley
CVX Chevron
$114.26 /

-2.94 (-2.51%)

11/24/21
Fly Intel: Top five analyst upgrades
11/24/21 RBC Capital
Chevron upgraded to Outperform from Sector Perform at RBC Capital
11/16/21 BofA
Chevron 'in the best shape of the past decade,' says BofA
11/15/21
Fly Intel: Top five analyst upgrades
COP ConocoPhillips
$71.45 /

-3.39 (-4.53%)

11/10/21 Societe Generale
ConocoPhillips downgraded to Hold from Buy at Societe Generale
11/08/21 Argus
ConocoPhillips price target raised to $89 from $66 at Argus
10/26/21 Mizuho
ConocoPhillips price target raised to $99 from $88 at Mizuho
10/21/21 Morgan Stanley
Exxon Mobil, Chevron look poised for 'catch up trade,' says Morgan Stanley
XOM Exxon Mobil
$61.17 /

-2.3 (-3.62%)

11/02/21
Fly Intel: Top five analyst downgrades
11/02/21 Truist
Exxon Mobil downgraded to Sell from Hold at Truist
11/02/21 Truist
Exxon Mobil downgraded to Sell from Hold at Truist
RDS.A Royal Dutch Shell
$42.06 /

-2.16 (-4.88%)

11/17/21 Scotiabank
Royal Dutch Shell upgraded to Outperform at Scotiabank
11/17/21 Scotiabank
Shell Class B upgraded to Outperform from Sector Perform at Scotiabank
11/15/21 UBS
Royal Dutch Shell price target raised to 2,125 GBp from 1,860 GBp at UBS
11/09/21 Morgan Stanley
Royal Dutch Shell price target raised to 2,136 GBp at Morgan Stanley
TOT TotalEnergies
/

+

09/30/21 Citi
Citi downgrades APA Corp. to Neutral on lack of near-term Suriname upside
07/22/21 HSBC
TotalEnergies price target lowered to EUR 41.90 from EUR 49 at HSBC
06/09/21
Fly Intel: Top five analyst initiations
06/09/21 MKM Partners
TotalEnergies initiated with a Buy at MKM Partners
ZM Zoom Video
$220.65 /

+12.41 (+5.96%)

XOM Exxon Mobil
$61.17 /

-2.3 (-3.62%)

UK Ucommune International
/

+

UAL United Airlines
$42.44 /

-4.29 (-9.18%)

TSLA Tesla
$1,082.15 /

-33.85 (-3.03%)

RDS.A Royal Dutch Shell
$42.06 /

-2.16 (-4.88%)

RCL Royal Caribbean
$68.14 /

-10.21 (-13.03%)

QSR Restaurant Brands
$57.95 /

-0.815 (-1.39%)

QGEN Qiagen
$56.42 /

+1.81 (+3.31%)

PTON Peloton
$46.33 /

+2.44 (+5.56%)

PFE Pfizer
$54.12 /

+3.22 (+6.33%)

PDD Pinduoduo
$68.52 /

-12.85 (-15.79%)

OCGN Ocugen
$6.47 /

-0.62 (-8.74%)

NVO Novo Nordisk
$108.19 /

-0.775 (-0.71%)

NCLH Norwegian Cruise Line
$20.22 /

-2.4 (-10.61%)

MSC Studio City
$6.66 /

-0.57 (-7.88%)

MRNA Moderna
$332.27 /

+59 (+21.59%)

MRK Merck
$78.24 /

-4.06 (-4.93%)

MLCO Melco Resorts & Entertainment
$10.39 /

-1.225 (-10.55%)

HUBS HubSpot
$806.16 /

+3.9899 (+0.50%)

DAL Delta Air Lines
$36.20 /

-3.48 (-8.77%)

CVX Chevron
$114.26 /

-2.94 (-2.51%)

COP ConocoPhillips
$71.45 /

-3.39 (-4.53%)

CCL Carnival
$17.98 /

-2.175 (-10.79%)

CANF Can-Fite BioPharma
$1.23 /

+0.05 (+4.24%)

BP BP
$25.83 /

-1.82 (-6.58%)

BNTX BioNTech
$353.00 /

+47.71 (+15.63%)

BABA Alibaba
$133.30 /

-3.32 (-2.43%)

AMZN Amazon.com
$3,509.00 /

-70.75 (-1.98%)

AAPL Apple
$157.52 /

-4.47 (-2.76%)

AAL American Airlines
$17.49 /

-1.97 (-10.12%)

  • 16
    Nov
  • 01
    Nov
  • 05
    Aug
  • 30
    Jun
  • 05
    Mar
  • 01
    Mar
  • 23
    Feb
  • 13
    Jan
ZM Zoom Video
$220.65 /

+12.41 (+5.96%)

XOM Exxon Mobil
$61.17 /

-2.3 (-3.62%)

UAL United Airlines
$42.44 /

-4.29 (-9.18%)

TSLA Tesla
$1,082.15 /

-33.85 (-3.03%)

TOT TotalEnergies
/

+

RDS.A Royal Dutch Shell
$42.06 /

-2.16 (-4.88%)

RCL Royal Caribbean
$68.14 /

-10.21 (-13.03%)

QSR Restaurant Brands
$57.95 /

-0.815 (-1.39%)

PTON Peloton
$46.33 /

+2.44 (+5.56%)

PFE Pfizer
$54.12 /

+3.22 (+6.33%)

PDD Pinduoduo
$68.52 /

-12.85 (-15.79%)

PBR Petrobras
$10.48 /

+ (+0.00%)

OCGN Ocugen
$6.47 /

-0.62 (-8.74%)

NCLH Norwegian Cruise Line
$20.22 /

-2.4 (-10.61%)

MRNA Moderna
$332.27 /

+59 (+21.59%)

MRK Merck
$78.24 /

-4.06 (-4.93%)

MLCO Melco Resorts & Entertainment
$10.39 /

-1.225 (-10.55%)

DIDI Didi
$7.87 /

-0.24 (-2.96%)

DAL Delta Air Lines
$36.20 /

-3.48 (-8.77%)

CVX Chevron
$114.26 /

-2.94 (-2.51%)

CCL Carnival
$17.98 /

-2.175 (-10.79%)

BP BP
$25.83 /

-1.82 (-6.58%)

BNTX BioNTech
$353.00 /

+47.71 (+15.63%)

BABA Alibaba
$133.30 /

-3.32 (-2.43%)

AMZN Amazon.com
$3,509.00 /

-70.75 (-1.98%)

AAPL Apple
$157.52 /

-4.47 (-2.76%)

AAL American Airlines
$17.49 /

-1.97 (-10.12%)

ZM Zoom Video
$220.65 /

+12.41 (+5.96%)

UAL United Airlines
$42.44 /

-4.29 (-9.18%)

TSLA Tesla
$1,082.15 /

-33.85 (-3.03%)

SCHYY Sands China
$26.54 /

+0.84 (+3.27%)

RCL Royal Caribbean
$68.14 /

-10.21 (-13.03%)

QSR Restaurant Brands
$57.95 /

-0.815 (-1.39%)

QGEN Qiagen
$56.42 /

+1.81 (+3.31%)

PTON Peloton
$46.33 /

+2.44 (+5.56%)

PDD Pinduoduo
$68.52 /

-12.85 (-15.79%)

OCGN Ocugen
$6.47 /

-0.62 (-8.74%)

NVO Novo Nordisk
$108.19 /

-0.775 (-0.71%)

NCLH Norwegian Cruise Line
$20.22 /

-2.4 (-10.61%)

MRNA Moderna
$332.27 /

+59 (+21.59%)

MRK Merck
$78.24 /

-4.06 (-4.93%)

MLCO Melco Resorts & Entertainment
$10.39 /

-1.225 (-10.55%)

LIAN LianBio
$16.06 /

+0.49 (+3.15%)

HUBS HubSpot
$806.16 /

+3.9899 (+0.50%)

DIDI Didi
$7.87 /

-0.24 (-2.96%)

DAL Delta Air Lines
$36.20 /

-3.48 (-8.77%)

COP ConocoPhillips
$71.45 /

-3.39 (-4.53%)

CCL Carnival
$17.98 /

-2.175 (-10.79%)

BP BP
$25.83 /

-1.82 (-6.58%)

BABA Alibaba
$133.30 /

-3.32 (-2.43%)

AMZN Amazon.com
$3,509.00 /

-70.75 (-1.98%)

AAPL Apple
$157.52 /

-4.47 (-2.76%)

AAL American Airlines
$17.49 /

-1.97 (-10.12%)

ZM Zoom Video
$220.65 /

+12.41 (+5.96%)

XOM Exxon Mobil
$61.17 /

-2.3 (-3.62%)

UAL United Airlines
$42.44 /

-4.29 (-9.18%)

TSLA Tesla
$1,082.15 /

-33.85 (-3.03%)

TOT TotalEnergies
/

+

RCL Royal Caribbean
$68.14 /

-10.21 (-13.03%)

PTON Peloton
$46.33 /

+2.44 (+5.56%)

PFE Pfizer
$54.12 /

+3.22 (+6.33%)

PDD Pinduoduo
$68.52 /

-12.85 (-15.79%)

PBR Petrobras
$10.48 /

+ (+0.00%)

OCGN Ocugen
$6.47 /

-0.62 (-8.74%)

NCLH Norwegian Cruise Line
$20.22 /

-2.4 (-10.61%)

MRNA Moderna
$332.27 /

+59 (+21.59%)

MRK Merck
$78.24 /

-4.06 (-4.93%)

MLCO Melco Resorts & Entertainment
$10.39 /

-1.225 (-10.55%)

DIDI Didi
$7.87 /

-0.24 (-2.96%)

DAL Delta Air Lines
$36.20 /

-3.48 (-8.77%)

CVX Chevron
$114.26 /

-2.94 (-2.51%)

COP ConocoPhillips
$71.45 /

-3.39 (-4.53%)

CCL Carnival
$17.98 /

-2.175 (-10.79%)

BP BP
$25.83 /

-1.82 (-6.58%)

BNTX BioNTech
$353.00 /

+47.71 (+15.63%)

BABA Alibaba
$133.30 /

-3.32 (-2.43%)

AMZN Amazon.com
$3,509.00 /

-70.75 (-1.98%)

AAPL Apple
$157.52 /

-4.47 (-2.76%)

AAL American Airlines
$17.49 /

-1.97 (-10.12%)

AAPL Apple
$157.52 /

-4.47 (-2.76%)

Recommendations
Moderna has been preparing for emergence of new variants, says Piper Sandler » 12:35
11/26/21
11/26
12:35
11/26/21
12:35
MRNA

Moderna

$330.03 /

+56.76 (+20.77%)

Piper Sandler analyst…

Piper Sandler analyst Edward Tenthoff reiterates his Overweight rating and $348 price target on Moderna shares as concern over a new SARS-CoV-2 variant, B.1.1529, sends markets lower in Friday trading. The company has "long warned and been preparing for" the emergence of new variants, said Tenthoff, who adds that mRNA technology is "ideally suited to rapidly swap in new versions of the Spike antigen" to make new COVID-19 vaccines and notes that the company has capacity to manufacture several hundred million vaccine doses every month. Heading into the market's early closing bell at 1 pm ET, Moderna shares are up $60.69, or 22%, to $334.08.

ShowHide Related Items >><<
MRNA Moderna
$330.03 /

+56.76 (+20.77%)

MRNA Moderna
$330.03 /

+56.76 (+20.77%)

11/23/21 Morgan Stanley
Positive flu vaccine data can drive Moderna 10%-20% higher, says Morgan Stanley
11/19/21 Piper Sandler
Moderna can gain share from Pfizer in booster market, says Piper Sandler
11/12/21 Piper Sandler
Piper keeps $348 target on Moderna after solid tumor data
11/08/21 Wolfe Research
Moderna initiated with an Outperform at Wolfe Research
MRNA Moderna
$330.03 /

+56.76 (+20.77%)

MRNA Moderna
$330.03 /

+56.76 (+20.77%)

MRNA Moderna
$330.03 /

+56.76 (+20.77%)

MRNA Moderna
$330.03 /

+56.76 (+20.77%)

Periodicals
Tesla unable to get EUR 1.1B in EU subsidies for German battery plant, FT says » 12:00
11/26/21
11/26
12:00
11/26/21
12:00
TSLA

Tesla

$1,091.30 /

-24.7 (-2.21%)

Tesla will not be able to…

Tesla will not be able to accept over EUR 1.1B in European subsidies for its planned battery plant in Germany after delays to the project breached a key condition of the funding, Peter Campbell, Joe Miller and Edward White of Financial Time's reported. The original application was through an EU program established in an effort to develop the battery industry in Europe. The EU requires fund recipients to be the "first industrial deployment" of the technology, according to official documents, meaning the batteries cannot already be made at another Tesla plant. Reference Link

ShowHide Related Items >><<
TSLA Tesla
$1,091.30 /

-24.7 (-2.21%)

TSLA Tesla
$1,091.30 /

-24.7 (-2.21%)

11/24/21 Morgan Stanley
Morgan Stanley stays Underweight Ford, admits to being wrong after near-double
11/19/21 Morgan Stanley
Apple Car would be 'ultimate EV bear case,' says Morgan Stanley
11/19/21 Wedbush
Tesla price target raised to $1,400 from $1,100 at Wedbush
11/17/21 Exane BNP Paribas
Exane BNP Paribas boosts Tesla target to $780, keeps Underpeform rating
TSLA Tesla
$1,091.30 /

-24.7 (-2.21%)

TSLA Tesla
$1,091.30 /

-24.7 (-2.21%)

TSLA Tesla
$1,091.30 /

-24.7 (-2.21%)

TSLA Tesla
$1,091.30 /

-24.7 (-2.21%)

Hot Stocks
Swissmedic approves booster dose of Moderna vaccine for adults 18 and over » 10:55
11/26/21
11/26
10:55
11/26/21
10:55
MRNA

Moderna

$337.75 /

+64.48 (+23.60%)

"This week, the…

"This week, the marketing authorization holder Moderna Switzerland GmbH submitted further data on the booster dose of its COVID-19 vaccine - Spikevax. Swissmedic has assessed the benefits and risks of a booster dose for adults in general, and has amended the product information. This means that all adults can now receive a booster with a half-dose of the vaccine at least six months after their second vaccination," the agency announced. Reference Link

ShowHide Related Items >><<
MRNA Moderna
$337.75 /

+64.48 (+23.60%)

MRNA Moderna
$337.75 /

+64.48 (+23.60%)

11/23/21 Morgan Stanley
Positive flu vaccine data can drive Moderna 10%-20% higher, says Morgan Stanley
11/19/21 Piper Sandler
Moderna can gain share from Pfizer in booster market, says Piper Sandler
11/12/21 Piper Sandler
Piper keeps $348 target on Moderna after solid tumor data
11/08/21 Wolfe Research
Moderna initiated with an Outperform at Wolfe Research
MRNA Moderna
$337.75 /

+64.48 (+23.60%)

MRNA Moderna
$337.75 /

+64.48 (+23.60%)

MRNA Moderna
$337.75 /

+64.48 (+23.60%)

MRNA Moderna
$337.75 /

+64.48 (+23.60%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.